ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype

[1]  J. Jagannathan,et al.  Evolving Cancer Classification in the Era of Personalized Medicine: A Primer for Radiologists , 2017, Korean journal of radiology.

[2]  M. Blüher.  Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance? , 2016, Clinical science.

[3]  F. Milagro,et al.  Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches. , 2016, Trends in pharmacological sciences.

[4]  H. Ichijo,et al.  ASK1 signalling regulates brown and beige adipocyte function , 2016, Nature Communications.

[5]  I. Harman-boehm,et al.  Decreased adiponectin links elevated adipose tissue autophagy with adipocyte endocrine dysfunction in obesity , 2016, International Journal of Obesity.

[6]  F. Pattou,et al.  E2F1 mediates sustained lipogenesis and contributes to hepatic steatosis. , 2016, The Journal of clinical investigation.

[7]  C. Kahn,et al.  CDK4 is an essential insulin effector in adipocytes. , 2016, The Journal of clinical investigation.

[8]  Prasenjit Manna,et al.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. , 2015, Metabolic syndrome and related disorders.

[9]  G. Sabio,et al.  Stress kinases in the modulation of metabolism and energy balance. , 2015, Journal of molecular endocrinology.

[10]  I. Harman-boehm,et al.  Elevated autophagy gene expression in adipose tissue of obese humans: A potential non-cell-cycle-dependent function of E2F1 , 2015, Autophagy.

[11]  K. Cianflone,et al.  Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction , 2015, Critical reviews in clinical laboratory sciences.

[12]  E. Blaak,et al.  Adipose Tissue Dysfunction and Impaired Metabolic Health in Human Obesity: A Matter of Oxygen? , 2015, Front. Endocrinol..

[13]  C. Culmsee,et al.  Central Inhibition of IKKβ/NF-κB Signaling Attenuates High-Fat Diet–Induced Obesity and Glucose Intolerance , 2015, Diabetes.

[14]  P. Trayhurn.  Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity. , 2014, Annual review of nutrition.

[15]  K. Clément,et al.  Adipocyte size threshold matters: link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. , 2014, The Journal of clinical endocrinology and metabolism.

[16]  L. Joosten,et al.  MAP3K8 (TPL2/COT) Affects Obesity-Induced Adipose Tissue Inflammation without Systemic Effects in Humans and in Mice , 2014, PloS one.

[17]  K. Clément,et al.  Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. , 2014, The Journal of clinical endocrinology and metabolism.

[18]  A. Rudich,et al.  A chromatin immunoprecipitation (ChIP) protocol for use in whole human adipose tissue. , 2013, American journal of physiology. Endocrinology and metabolism.

[19]  D. Bernlohr,et al.  Oxidative stress and protein carbonylation in adipose tissue - implications for insulin resistance and diabetes mellitus. , 2013, Journal of proteomics.

[20]  K. Clément,et al.  Fibrosis and adipose tissue dysfunction. , 2013, Cell metabolism.

[21]  N. Lundbom,et al.  Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype , 2013, Obesity.

[22]  C. Kahn,et al.  Lessons on Conditional Gene Targeting in Mouse Adipose Tissue , 2013, Diabetes.

[23]  M. Obin,et al.  'Metabolically healthy obesity': origins and implications. , 2013, Molecular aspects of medicine.

[24]  H. Shapiro,et al.  Adipose tissue foam cells are present in human obesity. , 2013, The Journal of clinical endocrinology and metabolism.

[25]  G. B. Buck Louis,et al.  Comparing apples and pears: women's perceptions of their body size and shape. , 2012, Journal of Women's Health.

[26]  R. Seger,et al.  The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. , 2011, Biochimica et biophysica acta.

[27]  Johan Auwerx,et al.  E2F transcription factor-1 regulates oxidative metabolism , 2011, Nature Cell Biology.

[28]  G. Shulman,et al.  Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance , 2011, Diabetes.

[29]  I. Harman-boehm,et al.  Altered autophagy in human adipose tissues in obesity. , 2010, The Journal of clinical endocrinology and metabolism.

[30]  Bent Stamnes.  Elevated , 2011, SIGGRAPH '11.

[31]  Richard T. Lee,et al.  Deletion of the α-Arrestin Protein Txnip in Mice Promotes Adiposity and Adipogenesis While Preserving Insulin Sensitivity , 2010, Diabetes.

[32]  C. Bogardus,et al.  Variants in ASK1 Are Associated With Skeletal Muscle ASK1 Expression, In Vivo Insulin Resistance, and Type 2 Diabetes in Pima Indians , 2010, Diabetes.

[33]  K. Clément,et al.  Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. , 2009, The Journal of clinical endocrinology and metabolism.

[34]  Y. Le Marchand-Brustel,et al.  Tpl2 Kinase Is Upregulated in Adipose Tissue in Obesity and May Mediate Interleukin-1β and Tumor Necrosis Factor-α Effects on Extracellular Signal–Regulated Kinase Activation and Lipolysis , 2009, Diabetes.

[35]  C. Drevon,et al.  Diet-induced obesity increases NF-κB signaling in reporter mice , 2009, Genes & Nutrition.

[36]  C. Sardet,et al.  The CDK4–pRB–E2F1 pathway controls insulin secretion , 2009, Nature Cell Biology.

[37]  M. Stumvoll,et al.  Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity. , 2009, The Journal of clinical endocrinology and metabolism.

[38]  J. Klein,et al.  Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy. , 2009, American journal of physiology. Endocrinology and metabolism.

[39]  D. Ginsberg,et al.  E2F1 regulates autophagy and the transcription of autophagy genes , 2008, Oncogene.

[40]  A. Rudich,et al.  Adipose stress-sensing kinases: linking obesity to malfunction , 2007, Trends in Endocrinology & Metabolism.

[41]  Margaret F. Gregor,et al.  Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease Published, JLR Papers in Press, May 9, 2007. , 2007, Journal of Lipid Research.

[42]  H. Ichijo,et al.  Thioredoxin and TRAF Family Proteins Regulate Reactive Oxygen Species-Dependent Activation of ASK1 through Reciprocal Modulation of the N-Terminal Homophilic Interaction of ASK1 , 2007, Molecular and Cellular Biology.

[43]  M. Stumvoll,et al.  Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. , 2007, Endocrinology.

[44]  M. Stumvoll,et al.  Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[45]  Margaret F. Gregor,et al.  Adipocyte stress: the endoplasmic reticulum and metabolic disease , 2007 .

[46]  D. Ginsberg,et al.  E2F1 Modulates p38 MAPK Phosphorylation via Transcriptional Regulation of ASK1 and Wip1* , 2006, Journal of Biological Chemistry.

[47]  A. Blais,et al.  ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene. , 2006, The Biochemical journal.

[48]  Kevin K. Yang,et al.  Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic Activity* , 2006, Journal of Biological Chemistry.

[49]  Xiaoqing Tang,et al.  An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARγ, adipogenesis, and insulin-responsive hexose transport , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Greenberg,et al.  Obesity and the role of adipose tissue in inflammation and metabolism. , 2006, The American journal of clinical nutrition.

[51]  Jean-Daniel Zucker,et al.  Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. , 2005, Diabetes.

[52]  J. Ninomiya-Tsuji,et al.  Involvement of ASK1 in Ca2+‐induced p38 MAP kinase activation , 2004, EMBO reports.

[53]  Michael Karin,et al.  A central role for JNK in obesity and insulin resistance , 2002, Nature.

[54]  J. Auwerx,et al.  E2Fs regulate adipocyte differentiation. , 2002, Developmental cell.

[55]  Kiyoshi Inoue,et al.  ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. , 2002, Genes & development.

[56]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[57]  Hong Liu,et al.  Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by Tumor Necrosis Factor Receptor-Associated Factor 2 Requires Prior Dissociation of the ASK1 Inhibitor Thioredoxin , 2000, Molecular and Cellular Biology.

[58]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β , 1998, Nature.

[59]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[60]  R. Gaynor,et al.  The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. , 1998, Nature.